Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.

Miyake Y, Iriguchi S, Kawana-Tachikawa A, Kitayama S, Imai E, Taya K, Ishii H, Miura T, Sakawaki H, Matano T, Kaneko S

Open source

DOI
10.3389/fimmu.2026.1883657
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1883657,
  title = {Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.},
  author = {Miyake Y and Iriguchi S and Kawana-Tachikawa A and Kitayama S and Imai E and Taya K and Ishii H and Miura T and Sakawaki H and Matano T and Kaneko S},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1883657},
  url = {https://doi.org/10.3389/fimmu.2026.1883657}
}

RIS

TY  - JOUR
TI  - Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.
AU  - Miyake Y
AU  - Iriguchi S
AU  - Kawana-Tachikawa A
AU  - Kitayama S
AU  - Imai E
AU  - Taya K
AU  - Ishii H
AU  - Miura T
AU  - Sakawaki H
AU  - Matano T
AU  - Kaneko S
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1883657
UR  - https://doi.org/10.3389/fimmu.2026.1883657
ER  - 

APA

Y, M., S, I., A, K., S, K., E, I., K, T., H, I., T, M., H, S., T, M., & S, K. (2026). Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantation.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1883657

Source records